Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, et al. Reply to Caldwell et al. Clin Infect Dis. 2022;75(1):180-181.

Saeed O, Panarelli N, Umrau K, Lee H, Westerhoff M, Cheng J, et al. The Histopathologic Features of Sickle Cell Hepatopathy: A Multi-Institutional Study. Am J Clin Pathol. 2022;157(1):73-81.

Casa D, Sung S, Mosquera JM, Rao R. Fine-needle aspiration biopsy of growing teratoma syndrome as a diagnostic pitfall of metastatic adenocarcinoma. Diagn Cytopathol. 2022;50(2):E71-E75.

Mukhopadhyay C, Zhou P. G3BP1 modulates SPOP to promote prostate tumorigenesis. Mol Cell Oncol. 2022;9(1):2030171.

Brieño-Enriquez MA, Duncan FE, Ghazi A, Klutstein M, Sebastiano V, Tyler J. Editorial: Germ cell development and reproductive aging. Front Cell Dev Biol. 2022;10:1051539.

Greenberg J, Limberg J, Verma A, Kim D, Chen X, Lee YJ, et al. Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration. JCI Insight. 2022;7(23).

Kim S, Au CM, Bin Jamalruddin MA, Abou-Ghali NE, Mukhtar E, Portella L, et al. AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer. Elife. 2022;11.

Xu B, Saliba M, Alzumaili B, Alghamdi M, Lee N, Riaz N, et al. Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis. Mod Pathol. 2022;35(11):1578-1586.

Nassar AH, Adib E, Alaiwi SA, Zarif TE, Groha S, Akl EW, et al. Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors. Cancer Cell. 2022;40(10):1161-1172.e5.

Kamran M, Bhattacharya U, Omar M, Marchionni L, Ince TA. ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin. NPJ Breast Cancer. 2022;8(1):99.